RxDoctor Payments Data

Ann Birka

Acute Care · Dallas, TXNPI 1306928288

Payments from drug & device makers

$6,544in general payments, 2019–2025

Across 64 payments — averaging $102.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$932
  • Boehringer Ingelheim$648
  • Novo Nordisk$531
  • AbbVie$504
  • Corcept Therapeutics$467
  • Sanofi-aventis U.S. LLC$377
  • plus $3K from 22 others

What the payments were for

  • Food & beverage$6,544100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,544 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.

See all acute care providers in Texas

Other acute care in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →